![Brian McNamee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 9 M $ al 31/05/2026
El Dr. Brian A. McNamee es director de Tarnagulla Ventures Pty Ltd. Forma parte del Consejo de Administración de Zenyth Therapeutics Ltd. Anteriormente, el Dr. McNamee fue director independiente de Gen-Probe, Inc., director general, director ejecutivo y médico de CSL Ltd., presidente de ZLB Behring LLC, director general de las divisiones de productos Faulding de FH Faulding & Co. Ltd., y director general de Pacific Biotechnology Ltd. También formó parte del consejo de Gen-Probe, Inc. y de la Peter Maccallum Cancer Foundation Ltd. Se licenció en la Universidad de Melbourne y se doctoró en la Universidad de Melbourne.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CSL LIMITED 0,03 % | 17/02/2026 | 127.628 ( 0,03 % ) | 9 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ZENYTH THERAPEUTICS LIMITED | Director/Miembro de la Junta | - |
| CSL LIMITED | Presidente | 17/10/2018 |
Geoff Ogilvy Foundation | Presidente | 01/05/2021 |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Presidente | - |
| Empresas | Cargo | Fin |
|---|---|---|
Genesis Care Pty Ltd.
 Genesis Care Pty Ltd. Hospital/Nursing ManagementHealth Services Provides cancer care services | Presidente | 01/06/2022 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Presidente | 01/07/2013 |
| CSL LIMITED | Presidente | 01/07/2013 |
Gen-Probe, Inc.
 Gen-Probe, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets nucleic acid probe-based products for clinical diagnosis | Director/Miembro de la Junta | 31/05/2007 |
Tarnagulla Ventures Pty Ltd.
 Tarnagulla Ventures Pty Ltd. Investment ManagersFinance Tarnagulla Ventures invests in companies located across the globe, primarily in Australia and the United States. The firm focuses on life science and healthcare sectors. It participates in seed and early stage capital requirements. | Inversor de Capital Privado | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 11 |
|---|---|
CSL Innovation Pty Ltd.
 CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets nucleic acid probe-based products for clinical diagnosis | Health Technology |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FH Faulding & Co. Ltd.
 FH Faulding & Co. Ltd. Pharmaceuticals: MajorHealth Technology Produces and wholesales pharmaceutical, household and allied products | Health Technology |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
Pacific Biotechnology Ltd. | |
Genesis Care Pty Ltd.
Genesis Care Pty Ltd. Hospital/Nursing ManagementHealth Services Provides cancer care services | Health Services |
Peter Maccallum Cancer Foundation Ltd. | |
Tarnagulla Ventures Pty Ltd.
Tarnagulla Ventures Pty Ltd. Investment ManagersFinance Tarnagulla Ventures invests in companies located across the globe, primarily in Australia and the United States. The firm focuses on life science and healthcare sectors. It participates in seed and early stage capital requirements. | Finance |
Geoff Ogilvy Foundation |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
